JP2016531120A5 - - Google Patents

Download PDF

Info

Publication number
JP2016531120A5
JP2016531120A5 JP2016531920A JP2016531920A JP2016531120A5 JP 2016531120 A5 JP2016531120 A5 JP 2016531120A5 JP 2016531920 A JP2016531920 A JP 2016531920A JP 2016531920 A JP2016531920 A JP 2016531920A JP 2016531120 A5 JP2016531120 A5 JP 2016531120A5
Authority
JP
Japan
Prior art keywords
human
cancer
medicament
ala
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016531920A
Other languages
English (en)
Japanese (ja)
Other versions
JP6692294B2 (ja
JP2016531120A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/049309 external-priority patent/WO2015017734A1/en
Publication of JP2016531120A publication Critical patent/JP2016531120A/ja
Publication of JP2016531120A5 publication Critical patent/JP2016531120A5/ja
Application granted granted Critical
Publication of JP6692294B2 publication Critical patent/JP6692294B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016531920A 2013-07-31 2014-07-31 腫瘍関連糖鎖抗原を標的として癌を治療及び予防するための組成物及び方法 Expired - Fee Related JP6692294B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361860827P 2013-07-31 2013-07-31
US61/860,827 2013-07-31
PCT/US2014/049309 WO2015017734A1 (en) 2013-07-31 2014-07-31 Compositions for and methods of treating and preventing cancer targeting tumor associated carbohydrate antigens

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020029957A Division JP2020100640A (ja) 2013-07-31 2020-02-26 腫瘍関連糖鎖抗原を標的として癌を治療及び予防するための組成物及び方法

Publications (3)

Publication Number Publication Date
JP2016531120A JP2016531120A (ja) 2016-10-06
JP2016531120A5 true JP2016531120A5 (https=) 2017-09-07
JP6692294B2 JP6692294B2 (ja) 2020-05-13

Family

ID=52432450

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016531920A Expired - Fee Related JP6692294B2 (ja) 2013-07-31 2014-07-31 腫瘍関連糖鎖抗原を標的として癌を治療及び予防するための組成物及び方法
JP2020029957A Pending JP2020100640A (ja) 2013-07-31 2020-02-26 腫瘍関連糖鎖抗原を標的として癌を治療及び予防するための組成物及び方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020029957A Pending JP2020100640A (ja) 2013-07-31 2020-02-26 腫瘍関連糖鎖抗原を標的として癌を治療及び予防するための組成物及び方法

Country Status (9)

Country Link
US (2) US10272144B2 (https=)
EP (1) EP3028048B1 (https=)
JP (2) JP6692294B2 (https=)
KR (1) KR20160037196A (https=)
AU (1) AU2014296038B2 (https=)
BR (1) BR112016001775A2 (https=)
CA (1) CA2919835A1 (https=)
DK (1) DK3028048T3 (https=)
WO (1) WO2015017734A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017023692A2 (pt) * 2015-05-01 2018-07-17 The Regents Of The University Of California moléculas imunoterapêuticas glican-dependentes
US10935544B2 (en) * 2015-09-04 2021-03-02 Obi Pharma, Inc. Glycan arrays and method of use
JP7458909B2 (ja) 2020-06-10 2024-04-01 東京応化工業株式会社 光硬化性組成物及びパターン形成方法

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB888702A (en) 1960-04-08 1962-01-31 Electro Hydraulics Ltd An hydraulic indexing device
US3055453A (en) 1961-05-10 1962-09-25 Andrew B Vanyo Collapsible trestle
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5036006A (en) 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5273525A (en) 1992-08-13 1993-12-28 Btx Inc. Injection and electroporation apparatus for drug and gene delivery
US5593972A (en) 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US5981505A (en) 1993-01-26 1999-11-09 The Trustees Of The University Of Pennsylvania Compositions and methods for delivery of genetic material
US5702359A (en) 1995-06-06 1997-12-30 Genetronics, Inc. Needle electrodes for mediated delivery of drugs and genes
US5993434A (en) 1993-04-01 1999-11-30 Genetronics, Inc. Method of treatment using electroporation mediated delivery of drugs and genes
US5439440A (en) 1993-04-01 1995-08-08 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
US20050049197A1 (en) 1993-09-14 2005-03-03 Epimmune Inc. Induction of immune response against desired determinants
DE69435171D1 (de) 1993-09-14 2009-01-08 Pharmexa Inc Pan dr-bindeproteinen zur erhöhung der immunantwort
US6413935B1 (en) 1993-09-14 2002-07-02 Epimmune Inc. Induction of immune response against desired determinants
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
NL9401820A (nl) 1994-11-02 1996-06-03 Meyn Maschf Inrichting voor het bewerken van aan zijn poten opgehangen gevogelte.
US5962428A (en) 1995-03-30 1999-10-05 Apollon, Inc. Compositions and methods for delivery of genetic material
US5810762A (en) 1995-04-10 1998-09-22 Genetronics, Inc. Electroporation system with voltage control feedback for clinical applications
PT876398E (pt) 1996-01-24 2002-12-31 Epimmune Inc Inducao de respostas imunitarias contra determinantes desejados
US6413517B1 (en) 1997-01-23 2002-07-02 Epimmune, Inc. Identification of broadly reactive DR restricted epitopes
CA2285056C (en) 1997-04-03 2004-12-14 Iacob Mathiesen Method for introducing pharmaceutical drugs and nucleic acids into skeletal muscle
US6261281B1 (en) 1997-04-03 2001-07-17 Electrofect As Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
AU8444798A (en) 1997-06-30 1999-01-25 Centre National De La Recherche Scientifique Improved method for transferring nucleic acid into the striped muscle and combination therefor
US6216034B1 (en) 1997-08-01 2001-04-10 Genetronics, Inc. Method of programming an array of needle electrodes for electroporation therapy of tissue
US6055453A (en) 1997-08-01 2000-04-25 Genetronics, Inc. Apparatus for addressing needle array electrodes for electroporation therapy
US6241701B1 (en) 1997-08-01 2001-06-05 Genetronics, Inc. Apparatus for electroporation mediated delivery of drugs and genes
US6135990A (en) 1997-12-17 2000-10-24 University Of South Florida Electroporation device and method
US6778853B1 (en) 1997-12-17 2004-08-17 University Of South Florida Electroporation device
US6120493A (en) 1998-01-27 2000-09-19 Genetronics, Inc. Method for the introduction of therapeutic agents utilizing an electroporation apparatus
US20030017497A1 (en) * 1998-02-04 2003-01-23 Thomas Kieber-Emmons Peptide mimotopes of carbohydrate antigens
AU3973599A (en) 1998-05-08 1999-11-29 Genetronics, Inc. Electrically induced vessel vasodilation
DE69940774D1 (de) 1998-06-17 2009-06-04 Idm Pharma Inc Hla-bindende peptide und ihre verwendungen
US6678556B1 (en) 1998-07-13 2004-01-13 Genetronics, Inc. Electrical field therapy with reduced histopathological change in muscle
US6697669B2 (en) 1998-07-13 2004-02-24 Genetronics, Inc. Skin and muscle-targeted gene therapy by pulsed electrical field
US6960566B1 (en) 1998-11-06 2005-11-01 The Wister Institute of Anatomy and Biology Compositions and methods for treatment of cancer
US20030224036A1 (en) 1999-12-13 2003-12-04 Fikes John D Hla class I a2 tumor associated antigen peptides and vaccine compositions
US20070098776A1 (en) 1999-12-13 2007-05-03 Fikes John D HLA class I A2 tumor associated antigen peptides and vaccine compositions
US6602510B1 (en) 2000-04-05 2003-08-05 Epimmune Inc. HLA class I A2 tumor associated antigen peptides and vaccine compositions
JP2003516344A (ja) 1999-12-13 2003-05-13 エピミューン, インコーポレイテッド Hlaクラスia2腫瘍関連抗原ペプチドおよびワクチン組成物
US7462354B2 (en) 1999-12-28 2008-12-09 Pharmexa Inc. Method and system for optimizing minigenes and peptides encoded thereby
CA2425648A1 (en) 2000-10-19 2002-04-19 Epimmune Inc. Hla class i and ii binding peptides and their uses
US7245963B2 (en) 2002-03-07 2007-07-17 Advisys, Inc. Electrode assembly for constant-current electroporation and use
JP4696079B2 (ja) * 2003-12-17 2011-06-08 ヤンセン アルツハイマー イミュノセラピー Aβ免疫原性ペプチド担体結合物およびそれの製造方法
GB0408164D0 (en) 2004-04-13 2004-05-19 Immune Targeting Systems Ltd Antigen delivery vectors and constructs
WO2006105255A2 (en) * 2005-03-29 2006-10-05 The Board Of Trustees Of The University Of Illinois Cancer vaccines and therapeutic methods
ITBO20060267A1 (it) * 2006-04-12 2007-10-13 Roberto Gambari Applicazione diagnostica e terapeutica di cellule ctl e nk selezionate funzionalmente
US20090142362A1 (en) * 2006-11-06 2009-06-04 Avant Immunotherapeutics, Inc. Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (CETP)
US8889143B2 (en) 2006-12-14 2014-11-18 Antigen Express, Inc. Ii-key/HER-2/neu hybrid cancer vaccine
EP2331130B1 (en) * 2008-04-09 2018-02-14 Oncoquest Inc. Ige antibodies for the treatment of cancer
EP2391635B1 (en) 2009-01-28 2017-04-26 Epimmune Inc. Pan-dr binding polypeptides and uses thereof
EP2485725A2 (en) * 2009-10-07 2012-08-15 Wyeth LLC Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof
CA2800911A1 (en) 2010-06-11 2011-12-15 University Of Georgia Research Foundation, Inc. Immunogenic vaccine
EP2407487A1 (en) * 2010-07-14 2012-01-18 F-Star Biotechnologische Forschungs - und Entwicklungsges. M.B.H. Multispecific modular antibody
JP2017518958A (ja) 2014-03-19 2017-07-13 マッカイ メディカル ファウンデイション ザ プレスビテリアン チャーチ イン タイワン マッカイ メモリアル ホスピタルMackay Medical Foundation The Presbyterian Church In Taiwan Mackay Memorial Hospital 免疫原性グリコペプチドに対する抗体、それを含む組成物、及びそれらの使用

Similar Documents

Publication Publication Date Title
US10597432B2 (en) Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers
KR102308798B1 (ko) 다양한 암의 면역요법 치료에서의 사용을 위한 펩티드, 펩티드의 조합 및 골격
IL294183A (en) shared neoantigens
TWI455721B (zh) 癌疫苗組合物
US20190030147A1 (en) Construction and methods of use of a therapeutic cancer vaccine library comprising fusion-specific vaccines
JP2015212268A5 (https=)
JP2012500001A5 (https=)
JP2018509935A5 (https=)
JP2007516966A5 (https=)
EA201201306A1 (ru) Новые способы иммунотерапии нескольких видов опухолей, в том числе рака желудочно-кишечного тракта и рака желудка
HUP0101734A2 (hu) Béta-amiloid prekurzor protein és ubiquitin-B kereteltolódásos mutánsok és alkalmazásuk
JP2019531293A5 (https=)
NZ601677A (en) Improved cancer therapy based on tumor associated antigens derived from cyclin d1
WO2009025196A1 (ja) Foxm1ペプチドおよびこれを含む薬剤
JP2016530290A5 (https=)
JP2010529026A5 (https=)
JP2012102105A5 (https=)
JP2014500278A5 (https=)
JP2016531120A5 (https=)
JP2018506287A5 (https=)
JP2018521977A5 (https=)
JP2019527676A5 (https=)
JP2014139185A5 (https=)
JP2019526261A5 (https=)
JP2018100243A5 (https=)